Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · OCTAVE SPECIALTY GROUP INC (OSG)

Octave Specialty Group Q3 2026 net loss narrows to $13.8 million from $31.7 million

Positive Impact 3 of 5 earnings

Octave Specialty Group reported third quarter 2026 results, with total revenue up 28% to $85.3 million and a net loss from continuing operations attributable to shareholders of $13.8 million, compared with $31.7 million a year earlier. The company also said that after quarter end, Everspan agreed to sell its Providence Washington Insurance Company subsidiary, which it expects to simplify its operating structure and strengthen its capital base.

Key points

  • Total revenue rose 28% to $85.3 million from $66.6 million in the third quarter of 2025.
  • Net loss from continuing operations attributable to shareholders was $13.8 million, or $0.31 per diluted share, versus $31.7 million, or $0.65 per share, a year earlier.
  • Adjusted EBITDA to shareholders was $3.3 million, compared with a loss of $2.9 million in the prior-year period.
  • Management expects market softening to continue into 2027; the earnings call is scheduled for November 10, 2026, at 8:30am ET.

The filing

CompanyOCTAVE SPECIALTY GROUP INC (OSG)
Form8-K, current report
Filed with the SECNov 9, 2026, 4:09 PM ET
Accession number0001628280-26-072166

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 6:16 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.